Request Legal Help Now - Free
LAWSUITS NEWS & LEGAL INFORMATION

Search Results for 

Sort by date 125 pages found matching Glaxo

  • Zantac Patent, GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute
    New York, NY: (Jan-28-08) Drug developer Cypress Pharmaceutical Inc. had been locked in a patent infringement lawsuit with a unit of British drug maker GlaxoSmithKline PLC related to a generic version of Glaxo's Zantac syrup to treat symptoms of heartburn. Sources close to the case stated that privately held Cypress Pharma said Glaxo agreed not to assert i...
  • Paxil Birth Defect Cases Continue on the Road to Settlement
    Jun-29-10 Washington, DC Expectant mothers who suffer from depression face a difficult decision: Paxil and other antidepressants have been linked to an increased risk of birth defects, yet many pregnant women are unable to manage their depression without medication. While the debate rages on over the best course of action, it seems that the US Food and Drug Admi...
  • Average Paxil Birth Defect Settlement $1.2 Million
    Aug-28-10 London, UK While no amount of money can adequately compensate for a life-altering birth defect allegedly caused by or linked to the use of the antidepressant Paxil, the average settlement in a Paxil birth defect lawsuit appears to be in excess of $1.2 million for each family involved. The Newark Star-Ledger noted in July that Paxil manufacturer GlaxoSm...
  • Glaxo Settles Paxil Side Effects Lawsuits, Average Settlement $1.2 Million
    Jul-28-10 Newark, NJ GlaxoSmithKline (Glaxo), the largest drug manufacturer in the UK, is believed to have paid out about $1 billion to settle various Paxil lawsuits since the drug first came onto the market in 1993. Earlier this month it was announced that Glaxo has agreed to pay another $1 billion to settle more than 800 outstanding cases alleging Paxil birth de...
  • Paxil Birth Defect Trial Tossed Out of Court
    Dec-1-10 Summerville, SC It was a heartbreaking end to a Paxil birth defects trial in Philadelphia, after a judge ended the proceedings at about the midway point, finding for GlaxoSmithKline (Glaxo), the defendant. The lawsuit, the first Paxil trial to be undertaken since Glaxo agreed in July to settle 800 cases by paying out more than $1 billion, attempted to...
  • Industry giants to pay $500,000 settlement in environmental lawsuit.
    San Francisco, CA: (May-19-08) The Department of Justice brought charges against GlaxoSmithKline Plc, Motorola Inc., and Siemens Corp., alleging that system failures at the companies' facilities led to the release of trichloroethylene, or TCE, into the public drinking water system in Scottsdale, AZ. The federal complaint stated that the three companies f...
  • Lawyer Accuses Drug Company of Ignoring Paxil Risks
    Sep-18-09 Philadelphia, PA GlaxoSmithKline ignored evidence about Paxil birth defects, according to a lawyer involved in a lawsuit regarding Paxil heart defects. The lawyer told the jury that Glaxo told scientists to avoid making public the risks of Paxil defects when the antidepressant was used by pregnant women. According to an article in The Philadelphia I...
  • FDA Medical Reviewer Slams RECORD Trial Conclusions, Casting Further Doubt on Avandia
    Jul-9-10 Washington, DC The US Food and Drug Administration (FDA) today stated through a posting on the official FDA website that GlaxoSmithKline (Glaxo), the manufacturer of Avandia , may have misinterpreted crucial details of a study that it said had vindicated Avandia and found the Type 2 diabetes drug to be safe. A medical reviewer with the FDA said that, c...
  • Part 2: Avandia, the FDA and the consumer: first lawsuit filed
    Jun-25-07 Beaumont, TX: It is now one month since GlaxoSmithKline's popular diabetes drug Avandia was reported to carry with it a higher risk of heart attack—and just two days ago, on June 19, what is likely the first lawsuit blaming Glaxo for contributing to just such a heart attack, was filed. Larry Alan Stanford, 60, of Beaumont, Texas, suffered a heart...
  • Former Glaxo Executive Indicted
    Nov-10-10 Durham, NC A long-promised crackdown on pharmaceutical executives accused of potential wrongdoing is gaining momentum with the indictment yesterday of a former vice president and legal counsel of GlaxoSmithKline (Glaxo). While the pharmaceutical giant is headquartered in the UK, its US operations are based in North Carolina. The New York Times reported...
  • Pharmaceutical Sales Overtime Debate Will Go On
    Apr-21-11 Portland, OR Long after the last appeal has been filed and the final arguments made, debate will continue to rage over whether or not individuals performing in pharmaceutical sales are entitled to overtime pay. Pharmaceutical reps promote the products of their employers—which are then prescribed to patients by doctors and dispensed through pharma...
  • Glaxo now faces Lawsuit by Shareholders over Avandia Problems
    Jun-16-07 New York, NY GlaxoSmithKline PLC, the maker of the popular diabetes drug Avandia, just can't stay out of the news. And the news is all bad. Since May 21, when a meta-analysis (that is, an analysis of pooled data) of 42 clinical trials involving nearly 28,000 diabetes patients was published, showing that those taking Avandia had a 43% higher risk of he...
  • GlaxoSmithKline Faces Zofran Birth Defect Lawsuits
    Mar-30-16 Pittsburgh, PA: GlaxoSmithKline faces more Zofran lawsuits alleging babies developed birth defects after being exposed to Zofran in the womb. While some women say their children have outgrown the Zofran side effects, others say the effects have lasted well into their child's life, and traumatized their families. With lawsuits consolidated for pretrial...
  • Avandia Settlement Reached in Burford Case
    London, UK: GlaxoSmithKline (GSK), has settled an Avandia lawsuit that alleged the diabetes medication caused the death of a North Carolina man. The suit was filed by the family of James Burford who died of a heart attack in 2006 while using the drug. The settlement was arranged the night before GSK was due to go to court over the case, which is t...
  • Coming Out from the Shadow of Paxil Birth Defects
    Dec-13-11 Washington, DC Anyone sitting on the fence over whether or not to go after GlaxoSmithKline (Glaxo) over Paxil side effects need only contemplate the reported $3 billion that Glaxo has agreed in principal to pay, in order to settle charges of off-label marketing and fraud. Combine that figure with the reported $1 billion Glaxo is believed to have paid...
  • Glaxo $750 Million Settlement Fourth-Largest in History
    Oct-28-10 Boston, MA A whistleblower is $96 million richer after bringing a federal False Claims Act (FCA) lawsuit against UK pharmaceutical giant GlaxoSmithKline (Glaxo) over deviations in good manufacturing practices at a former plant in Puerto Rico. In total, Glaxo agreed to pay $750 million in penalties and will plead guilty to a criminal charge in rela...
  • Avandia Decline Not Affecting GlaxoSmithKline
    May-3-09 Philadelphia, PA While profits may have been down in the first quarter when compared to a year ago, Avandia manufacturer GlaxoSmithKline (Glaxo) appears to be doing well. And while the risk for heart attack and other Avandia side effects continues for Type 2 diabetes patients—and critics continue to lobby for an Avandia recall—Glaxo's own health appe...
  • Glaxo Looking to Advance Rest of OTC Asset Sales As Alli Side Effects Remain
    Feb-1-12 London, England GlaxoSmithKline Plc is trying to sell its remaining over-the-counter medicine brands as quickly as possible, due to the ongoing issues with Alli side effects and other medications, according to Bloomberg . The news outlet reported that the company's chief financial officer noted that they are continuing the process of divesting other...
  • GlaxoSmithKline Paxil Monopoly Settlement
    The New York Attorney General filed a lawsuit against the drug manufacturer on behalf of 49 states for allegedly creating a monopoly of its anti-depressant drug Paxil. Glaxo allegedly used frivolous patent infringement lawsuits against generic producers of Paxil to keep the drug's cost higher than necessary. By holding a monopoly for a popular drug, con...
  • Was GlaxoSmithKline Worried About Avandia Risks?
    Sep-23-09 Seattle, WA For patients who take Avandia, learning about the risk of Avandia side effects may have come as a complete surprise before the strengthened warnings were added in 2007. However, reports have surfaced that GlaxoSmithKline, maker of Avandia, may have known about the risks before studies were released questioning the drug's safety. An articl...
Page: 1  2  3  4  5  6  7     Next»


Request Legal Help Now! - Free